Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why
FDA approves updated Covid-19 vaccines
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | Morningstar
BioNTech (BNTX) Rallied on Moderna's Win. Does a Competitor's Success Validate its Oncology Pipeline?
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips
$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges
Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.
Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips
BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing
BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data - What's Changed
BioNTech (BNTX) Stock Looks Fully Priced As It Rebounds From A 67% Fall
BioNTech (BNTX) Presents New Lung Cancer Data, Is The Stock Already Fully Valued?
Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session
BioNTech (NASDAQ:BNTX) Shares Up 7.4% - Here's What Happened - Daily Political
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips
Flossbach Von Storch SE Makes New Investment in BioNTech SE Sponsored ADR $BNTX
BioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why
Moderna Rockets 93%, Merck Jumps 7% as Melanoma Therapy Meets Primary Goal in Phase 3 Trial
Biotech Stocks To Keep An Eye On - August 19th - Daily Political
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Brokerages
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives $127.81 Average Target Price from Analysts - Daily Political
BioNTech's oncology pivot comes with a new CEO
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages
BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance
Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX
Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Stock Observer
Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX
Citigroup Cuts BioNTech (NASDAQ:BNTX) Price Target to $125.00
Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX
BioNTech (NASDAQ:BNTX) Rating Lowered to Sell at Wall Street Zen
BioNTech SE Q2 Loss Rises
BioNTech deep in the red as demand for vaccines falls
BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar
BioNTech Q2 Earnings Call Highlights
BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market
BioNTech Cuts 2026 Sales Forecast Amid Declining COVID Vaccine Demand, ETPharma
BioNTech lowers 2026 sales outlook as COVID vaccine demand softens
BioNTech taps Sobi executive Oelkers as its next CEO
BioNTech says Sobi's Oelkers will replace Sahin as CEO - AOL
EU greenlights Pfizer and BioNTech's new COVID vaccine
Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | Morningstar
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
